NEUROG1 and cutaneous melanoma: Evidence also suggests that the combination of AKA kinase inhibition might potentiate the response to immunotherapy: in one study, AKA inhibition in immunocompetent mice models with skin melanoma cell lines led to reduced tumor growth, upregulation of genes involved with immune response, as well as an increased T cell infiltrate [79].